The genomics and genetics of endometrial cancer
Authors:
- Daphne W BellDBDaphne W Bell
- O'H AraOAO'H Ara
- Andrea J O'HaraAOAndrea J O'Hara
Open Access
- 1 March 2012
- journal article
- review article
- Published by Taylor & Francis in Advances in Genomics and Genetics
- Vol. 2 (2) , 33-47
Abstract
Most sporadic endometrial cancers (ECs) can be histologically classified as endometrioid, serous, or clear cell. Each histotype has a distinct natural history, clinical behavior, and genetic etiology. Endometrioid ECs have an overall favorable prognosis. They are typified by high frequency genomic alterations affecting PIK3CA, PIK3R1, PTEN, KRAS, FGFR2, ARID1A (BAF250a), and CTNNB1 (β-catenin), as well as epigenetic silencing of MLH1 resulting in microsatellite instability. Serous and clear cell ECs are clinically aggressive tumors that are rare at presentation but account for a disproportionate fraction of all endometrial cancer deaths. Serous ECs tend to be aneuploid and are typified by frequent genomic alterations affecting TP53 (p53), PPP2R1A, HER-2/ERBB2, PIK3CA, and PTEN; additionally, they display dysregulation of E-cadherin, p16, cyclin E, and BAF250a. The genetic etiology of clear cell ECs resembles that of serous ECs, but it remains relatively poorly defined. A detailed discussion of the characteristic patterns of genomic alterations that distinguish the three major histotypes of endometrial cancer is reviewed herein.Keywords
This publication has 157 references indexed in Scilit:
- A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinomaCancer, 2010
- Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesisInternational Journal of Cancer, 2008
- The Catalogue of Somatic Mutations in Cancer (COSMIC)Current Protocols in Human Genetics, 2008
- Low frequency of BRAF and CDKN2A mutations in endometrial cancerInternational Journal of Cancer, 2005
- Genomic aberrations in carcinomas of the uterine corpusGenes, Chromosomes and Cancer, 2004
- Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinomaCancer, 2002
- Genotypic and phenotypic progression in endometrial tumorigenesis: Determining when defects in DNA mismatch repair and KRAS2 occurGenes, Chromosomes and Cancer, 2001
- Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometryThe Journal of Pathology, 2000
- Microsatellite instability in endometrial carcinomas: Frequent replication errors in tumors of early onset and/or of poorly differentiated typeGenes, Chromosomes and Cancer, 1995
- The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patientsCancer, 1985